Orelabrutinib (ICP-022) - Moligand™, ≥98% , Tyrosine-protein kinase BTK inhibitor, CAS No.1655504-04-3, Tyrosine-protein kinase BTK inhibitor

CAS: 1655504-04-3 Cat. No.: O414422 Molecular Weight: 427.49
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
AC-36680 | ICP022 | ICP-022 | Orelabrutinib | 6-(1-(1-Oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-3-pyridinecarboxamide | HY-129390 | F88710 | HY-108451 | NSC826039 | NSC-826039 | ORELABRUTINIB [WHO-DD] | 2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpip
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
5mg
O414422-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$261.90
10mg
O414422-10mg
3
$391.90
25mg
O414422-25mg
3
$783.90
50mg
O414422-50mg
2
$1,455.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

Orelabrutinib (ICP-022) Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK) . Orelabrutinib has potential antineoplastic activity.


Targets

BTK


In vitro

Orelabrutinib potently inhibits BTK enzymatic activity with an IC50 value of 1.6 nM. In KINOMEscan assay conducted in parallel at 1 μM against a panel of 456 kinases, orelabrutinib only targets BTK with > 90% inhibition while ibrutinib inhibits additional many other kinases including EGFR, TEC and BMX, demonstrating orelabrutinib\'s superior kinase selectivity.


In vivo

Orelabrutinib has a favorable PK profile with an ideal T1/2 (~1.5-4 h) and good oral bioavailability (~20-80%) as well as prolonged BTK target occupancy in preclinical PK/PD studies. The superior selectivity translates into improved safety profile and large safety window in the GLP toxicology studies in rats and dogs.

Specifications

Synonyms
AC-36680 | ICP022 | ICP-022 | Orelabrutinib | 6-(1-(1-Oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-3-pyridinecarboxamide | HY-129390 | F88710 | HY-108451 | NSC826039 | NSC-826039 | ORELABRUTINIB [WHO-DD] | 2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpip
Specifications & Purity
Moligand™, ≥98%
Biochemical and Physiological Mechanisms
Orelabrutinib (ICP-022) is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK). Orelabrutinib has potential antineoplastic activity.
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Tyrosine-protein kinase BTK inhibitor
Purity
≥98%
Product Properties
ALogP4.055
hba_count4
HBD Count1
Rotatable Bond6
Names and Identifiers
Pubchem Sid504772644
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504772644
Canonical SmilesC=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4
IUPAC Name2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpiperidin-4-yl)pyridine-3-carboxamide
InChIKeyMZPVEMOYADUARK-UHFFFAOYSA-N
INCHI1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31)
Isomeric SMILES C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4
Molecular Weight 427.49
Reaxy-Rn 28089169
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=28089169&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassDiphenylethers
Intermediate Tree Nodes Not available
Direct ParentDiphenylethers
Alternative Parents Phenylpyridines  Diarylethers  N-acylpiperidines  Nicotinamides  Phenoxy compounds  Phenol ethers  Acrylic acids and derivatives  Tertiary carboxylic acid amides  Heteroaromatic compounds  Primary carboxylic acid amides  Azacyclic compounds  Hydrocarbon derivatives  Carbonyl compounds  Organonitrogen compounds  Organic oxides  Organic anions  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Diphenylether - 2-phenylpyridine - Diaryl ether - N-acyl-piperidine - Nicotinamide - Pyridinecarboxamide - Pyridine carboxylic acid or derivatives - Phenol ether - Phenoxy compound - Piperidine - Pyridine - Tertiary carboxylic acid amide - Acrylic acid or derivatives - Heteroaromatic compound - Carboxamide group - Primary carboxylic acid amide - Organoheterocyclic compound - Carboxylic acid derivative - Azacycle - Ether - Organic oxide - Organic oxygen compound - Organonitrogen compound - Carbonyl group - Organooxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Organic anion - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as diphenylethers. These are aromatic compounds containing two benzene rings linked to each other through an ether group.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
BTK Tclin Tyrosine-protein kinase BTK (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Tec Tyrosine-protein kinase TEC (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
G2229185Certificate of AnalysisMay 12, 2025 O414422
G2229186Certificate of AnalysisMay 12, 2025 O414422
G2229187Certificate of AnalysisMay 12, 2025 O414422
Chemical and Physical Properties
SolubilitySolubility (25°C) In vitro DMSO: 86 mg/mL (201.17 mM); Ethanol: 10 mg/mL (23.39 mM); Water: Insoluble;
DMSO(mg / mL) Max Solubility86
DMSO(mM) Max Solubility201.174296474771
Water(mg / mL) Max Solubility<1
Molecular Weight427.500 g/mol
XLogP33.600
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass427.19 Da
Monoisotopic Mass427.19 Da
Topological Polar Surface Area85.500 Ų
Heavy Atom Count32
Formal Charge0
Complexity647.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.